Focused on use of synthetic biology techniques to engineer mammalian cells for a wide variety of applications.
- Year invested 2016
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Website sentibio.com/
- Company Status IPO/Acquired (by Dynamics Special Purpose Corp.) (NASDAQ: SNTI)